Scivation pulled their widely hyped pre-workout supplement Psycho after they received some bad results with the beta testing samples. They nailed the issue down to the ingredient alpha yohimbine, then pulled the product altogether, taking it back to the drawing board. On the brighter side the latest update from the brand does suggest that they are on track for the predicted 12 week launch delay. Scivation’s CEO has confirmed the new formula is about one or two steps away from being ready to go. Much like the first round of Psycho, they have yet to release anything in regards to contents. But with such a short turn around there isn’t likely to be that much of change compared to the original version. Especially since Scivation claimed to be working on the pre-workout for around two years. A massive amount of effort they are unlikely to reproduce in the three month reformulation period. You can check out the Psycho’s first round facts panel below.
